Dmitrij Hristodorov

Dmitrij Hristodorov joined Forbion in March 2020.

Dmitrij is Principal in the Munich office and joined the Forbion team in 2020.

Prior to joining Forbion, Dmitrij was Senior Director of Global Business Development & Licensing at Bayer Pharma where he was mainly responsible for Ophthalmology, Cardiology, Nephrology and Pulmonology. His spectrum of activities included scouting, evaluation, negotiation and transaction for in- and out-licensing.

Before joining the Business Development Group at Bayer Pharma, Dmitrij spent two years in R&D where he was Head of Pharmacology Lab in Ophthalmology. His role encompassed activities ranging from target discovery to start of preclinical development.

Dmitrij received his PhD in Immunology (summa cum laude) from the University of Aachen/Fraunhofer IME in 2013.